{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T00:18:43Z","timestamp":1792023523230,"version":"4.4.0"},"reference-count":148,"publisher":"FapUNIFESP (SciELO)","issue":"2 suppl 1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["An. Bras. Dermatol."],"DOI":"10.1590\/abd1806-4841.20198607","type":"journal-article","created":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T19:50:50Z","timestamp":1559418650000},"page":"7-19","source":"Crossref","is-referenced-by-count":62,"title":["Consensus on the treatment of hidradenitis suppurativa - Brazilian Society of Dermatology"],"prefix":"10.1590","volume":"94","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9170-932X","authenticated-orcid":false,"given":"Renata Ferreira","family":"Magalh\u00e3es","sequence":"first","affiliation":[{"name":"Universidade Estadual de Campinas, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2910-7330","authenticated-orcid":false,"given":"Maria Cec\u00edlia","family":"Rivitti-Machado","sequence":"additional","affiliation":[{"name":"Universidade de S\u00e3o Paulo, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4160-5447","authenticated-orcid":false,"given":"Gleison Vieira","family":"Duarte","sequence":"additional","affiliation":[{"name":"Instituto Bahiano de Imunoterapia, Brasil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7136-6008","authenticated-orcid":false,"given":"Roberto","family":"Souto","sequence":"additional","affiliation":[{"name":"Universidade do Estado do Rio de Janeiro, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1303-5419","authenticated-orcid":false,"given":"Daniel Holthausen","family":"Nunes","sequence":"additional","affiliation":[{"name":"Universidade Federal de Santa Catarina, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2943-0322","authenticated-orcid":false,"given":"Mario","family":"Chaves","sequence":"additional","affiliation":[{"name":"Universidade do Estado do Rio de Janeiro, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4026-9664","authenticated-orcid":false,"given":"S\u00e9rgio Henrique","family":"Hirata","sequence":"additional","affiliation":[{"name":"Universidade Federal de S\u00e3o Paulo, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7982-9107","authenticated-orcid":false,"given":"Andrea Machado Coelho","family":"Ramos","sequence":"additional","affiliation":[{"name":"Universidade Federal de Minas Gerais, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"530","published-online":{"date-parts":[[2019,4]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/j.ad.2015.06.004","article-title":"Actualizaci\u00f3n en hidradenitis supurativa (I): epidemiolog\u00eda, aspectos cl\u00ednicos y definici\u00f3n de severidad de la enfermedad","volume":"106","author":"Martorell A","year":"2015","journal-title":"Actas Dermosifiliogr"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1111\/ijd.13937","article-title":"Prevalence of hidradenitis suppurativa in Brazil: a population survey","volume":"57","author":"Ianhez M","year":"2018","journal-title":"Int J Dermatol"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1111\/jdv.14741","article-title":"Consensus on the management of patients with psoriatic arthritis in a dermatology setting","volume":"32","author":"Gisondi P","year":"2018","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.ad.2013.07.001","article-title":"Elaboraci\u00f3n mediante el metodo Delphi de recomendaciones para el manejo coordinado (reumat\u00f3logo\/dermat\u00f3logo de la artritis psori\u00e1sica","volume":"105","author":"Canete JD","year":"2014","journal-title":"Actas Dermassifiliogr"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1080\/01621459.1937.10503522","article-title":"The use of ranks to avoid the assumption of normality implicit in the analysis of variance","volume":"32","author":"Friedman M","year":"1937","journal-title":"Journal of the American Statistical Association"},{"key":"ref6","series-title":"Centre for Evidence Based Medicine (CEBM). Oxford Center for Evidence-based Medicine - Levels of Evidence","year":"2012"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"112","DOI":"10.12703\/P6-112","article-title":"Update on hidradenitis suppurativa: connecting the tracts","volume":"6","author":"Gill L","year":"2014","journal-title":"F1000Prime Rep"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.det.2015.08.004","article-title":"Inflammatory Mechanisms in Hidradenitis Suppurativa","volume":"34","author":"Kelly G","year":"2016","journal-title":"Dermatol Clin"},{"issue":"5","key":"ref9","doi-asserted-by":"crossref","first-page":"S8","DOI":"10.1016\/j.jaad.2015.07.045","article-title":"Pathophysiology of hidradenitis suppurativa : An update","volume":"73","author":"Prens E","year":"2015","journal-title":"J Am Acad Dermatol"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"9","DOI":"10.4161\/derm.2.1.12490","article-title":"Comorbidities of hidradenitis suppurativa (acne inversa)","volume":"2","author":"Fimmel S","year":"2010","journal-title":"Dermatoendocrinol"},{"issue":"5","key":"ref11","doi-asserted-by":"crossref","first-page":"S27","DOI":"10.1016\/j.jaad.2015.07.055","article-title":"Systemic associations of hidradenitis suppurativa","volume":"73","author":"Kohorst JJ","year":"2015","journal-title":"J Am Acad Dermatol"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.det.2015.08.002","article-title":"Prevalence, risk factors, and comorbidities of hidradenitis suppurativa","volume":"34","author":"Miller IM","year":"2016","journal-title":"Dermatol Clin"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/j.jaad.2013.11.014","article-title":"The prevalence of metabolic syndrome in patients with hidradenitis suppurativa","volume":"70","author":"Gold DA","year":"2014","journal-title":"J Am Acad Dermatol"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1001\/jamadermatol.2015.6264","article-title":"Risk of major adverse cardiovascular events and all-cause mortality in patients with hidradenitis suppurativa","volume":"152","author":"Egeberg A","year":"2016","journal-title":"JAMA Dermatol"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/j.jaad.2006.08.061","article-title":"Quality of life impairment in hidradenitis suppurativa: a study of 61 cases","volume":"56","author":"Wolkenstein P","year":"2007","journal-title":"J Am Acad Dermatol"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1159\/000443878","article-title":"The ABC of Hidradenitis Suppurativa: A Validated Glossary on how to Name Lesions","volume":"232","author":"Lipsker D","year":"2016","journal-title":"Dermatology"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1111\/j.1600-0625.2012.01552.x","article-title":"Hidradenitis suppurativa: viewpoint on clinical phenotyping, pathogenesis and novel treatments","volume":"21","author":"van der Zee HH","year":"2012","journal-title":"Exp Dermatol"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1177\/000313481608200423","article-title":"Recalcitrant Hidradenitis Suppurativa: An investigation of demographics, surgical management, bacterial isolates, pharmacologic intervention, and patient-reported health outcome","volume":"82","author":"Thomas C","year":"2016","journal-title":"Am Surg"},{"key":"ref19","article-title":"Squamous cell carcinoma in the setting of chronic hidradenitis suppurativa; report of a patient and update of the literature","volume":"21","author":"Pena ZG","year":"2015","journal-title":"Dermatol Online J"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1097\/DSS.0000000000001147","article-title":"Ultrasound Evaluation as a Complementary Test in Hidradenitis Suppurativa: Proposal of a Standarized Repor","volume":"43","author":"Martorell A","year":"2017","journal-title":"Dermatol Surg"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1159\/000431175","article-title":"Hidradenitis Suppurativa \/ Acne Inversa : Criteria for diagnosis , severity assessment , classification and disease evaluation","volume":"231","author":"Zouboulis CC","year":"2015","journal-title":"Dermatology"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1111\/jdv.12966","article-title":"European S1 guideline for the treatment of hidradenitis suppurativa\/acne inversa","volume":"29","author":"Zouboulis CC","year":"2015","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1111\/bjd.15748","article-title":"Development and Validation of the International Hidradenitis Suppurativa Severity Score System (IHS4), a novel dynamic scoring system to assess HS severity","volume":"177","author":"Zouboulis CC","year":"2017","journal-title":"Br J Dermatol"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1111\/bjd.13270","article-title":"Assessing the validity, responsiveness and meaningfulness of the Hidradenitis Suppurativa Clinical Response (HiSCR) as the clinical endpoint for hidradenitis suppurativa treatment","volume":"171","author":"Kimball AB","year":"2014","journal-title":"Br J Dermatol"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1038\/jid.2012.472","article-title":"Identification of three hidradenitis suppurativa phenotypes: latent class analysis of a cross-sectional study","volume":"133","author":"Canoui-Poitrine F","year":"2013","journal-title":"J Invest Dermatol"},{"issue":"Suppl 1","key":"ref26","doi-asserted-by":"crossref","first-page":"S23","DOI":"10.1016\/j.jaad.2015.07.047","article-title":"New insights into the diagnosis of hidradenitis suppurativa: clinical presentations and phenotypes","volume":"73","author":"van der Zee HH","year":"2015","journal-title":"J Am Acad Dermatol"},{"key":"ref27","first-page":"260","article-title":"T helper 17 cell\/regulatory T-cell imbalance in hidradenitis suppurativa\/acne inversa: the link to hair follicle dissection, obesity, smoking and autoimmune comorbidities","volume":"179","author":"Melnik BC","year":"2018","journal-title":"Br J Dermatol"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1111\/jdv.13059","article-title":"Resolution of hidradenitis suppurativa after weight loss by dietary measures, especially on frictional locations","volume":"30","author":"Boer J","year":"2016","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1111\/ced.12269","article-title":"Rapid resolution of hidradenitis suppurativa after bariatric surgical intervention","volume":"39","author":"Thomas CL","year":"2014","journal-title":"Clin Exp Dermatol"},{"key":"ref30","first-page":"553","article-title":"The influence of body weight on the prevalence and severity of hidradenitis suppurativa","volume":"94","author":"Kromann CB","year":"2014","journal-title":"Acta DermVenereol"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1007\/s40257-017-0280-2","article-title":"Assessing Pruritus in Hidradenitis Suppurativa: A Cross-Sectional Study","volume":"18","author":"Vossen ARJV","year":"2017","journal-title":"Am J Clin Dermatol"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1111\/ced.13025","article-title":"Prodromal symptoms in hidradenitis suppurativa","volume":"42","author":"Ring HC","year":"2017","journal-title":"Clin Exp Dermatol"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1111\/j.1365-2133.2009.09198.x","article-title":"Objective scoring of hidradenitis suppurativa reflecting the role of tobacco smoking and obesity","volume":"161","author":"Sartorius K","year":"2009","journal-title":"Br J Dermatol"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1159\/000018126","article-title":"Cigarette smoking as a triggering factor of hidradenitis suppurativa","volume":"198","author":"K\u00f6nig A","year":"1999","journal-title":"Dermatology"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1111\/bjd.13090","article-title":"Risk factors, clinical course and long-term prognosis in hidradenitis suppurativa: a cross-sectional study","volume":"171","author":"Kromann CB","year":"2014","journal-title":"Br J Dermatol"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1016\/j.bpobgyn.2014.07.012","article-title":"Hidradenitis suppurativa","volume":"28","author":"Margesson LJ","year":"2014","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1159\/000472252","article-title":"Should hidradenitis suppurativa be included in dermatoses showing koebnerization? Is it friction or fiction?","volume":"233","author":"Boer J","year":"2017","journal-title":"Dermatology"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.det.2015.08.011","article-title":"The Role of mechanical stress in hidradenitis suppurativa","volume":"34","author":"Boer J","year":"2016","journal-title":"Dermatol Clin"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.jdermsci.2016.08.010","article-title":"Combination of oral zinc gluconate and topical triclosan: An anti-inflammatory treatment modality for initial hidradenitis suppurativa","volume":"84","author":"Hessam S","year":"2016","journal-title":"J Dermatol Sci"},{"issue":"Suppl 2","key":"ref40","doi-asserted-by":"crossref","first-page":"S35","DOI":"10.1111\/j.1529-8019.2008.00231.x","article-title":"Sensitizing potential of triclosan and triclosan-based skin care products in patients with chronic eczema","volume":"21","author":"Schena D","year":"2008","journal-title":"Dermatol Ther"},{"issue":"5","key":"ref41","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1111\/j.1745-7599.2007.00219.x","article-title":"Current understanding and management of hidradenitis suppurativa","volume":"19","author":"Krbec AC","year":"2007","journal-title":"J Am Acad Nurse Pract"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1055\/s-0031-1272826","article-title":"Hidradenitis suppurativa and pruritus ani","volume":"24","author":"Asgeirsson T","year":"2011","journal-title":"Clin Colon Rectal Surg"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.jdermsci.2017.04.006","article-title":"A retrospective institutional study of the association of smoking with the severity of hidradenitis suppurativa","volume":"87","author":"Dessinioti C","year":"2017","journal-title":"J Dermatol Sci"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1111\/j.1524-4725.2009.01214.x","article-title":"Randomized control trial for the treatment of hidradenitis suppurativa with a neodymium-doped yttrium aluminium garnet laser","volume":"35","author":"Tierney E","year":"2009","journal-title":"Dermatol Surg"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/j.jaad.2009.07.048","article-title":"Prospective controlled clinical and histopathologic study of hidradenitis suppurativa treated with the long-pulsed neodymium: yttrium-aluminum-garnet laser","volume":"62","author":"Mahmoud BH","year":"2010","journal-title":"J Am Acad Dermatol"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.det.2015.08.006","article-title":"Medical treatments of hidradenitis suppurativa: more options, less evidence","volume":"34","author":"van der Zee HH","year":"2016","journal-title":"Dermatol Clin"},{"issue":"Suppl 1","key":"ref47","doi-asserted-by":"crossref","first-page":"S55","DOI":"10.1016\/j.jaad.2015.07.048","article-title":"Local wound care and topical management of hidradenitis suppurativa","volume":"73","author":"Alavi A","year":"2015","journal-title":"J Am Acad Dermatol"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/S0190-9622(98)70272-5","article-title":"Topical clindamycin versus systemic tetracycline in the treatment of hidradenitis suppurativa","volume":"39","author":"Jemec GB","year":"1998","journal-title":"J Am Acad Dermatol"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1111\/bjd.13866","article-title":"Management of hidradenitis suppurativa: a UK survey of current practice","volume":"173","author":"Ingram JR","year":"2015","journal-title":"Br J Dermatol"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1056\/NEJMcp1014163","article-title":"Clinical practice. Hidradenitis suppurativa","volume":"366","author":"Jemec GB","year":"2012","journal-title":"N Engl J Med"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1080\/09546634.2016.1273470","article-title":"Effective modified conservative tissue preserving protocol to treat stage I axillary hidradenitis suppurativa: a prospective cohort study of 627 patients with five years follow-up","volume":"28","author":"Shirah BH","year":"2017","journal-title":"J Dermatolog Treat"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1684\/ejd.2010.0833","article-title":"Fusidic acid in dermatology: an updated review","volume":"20","author":"Sch\u00f6fer H","year":"2010","journal-title":"Eur J Dermatol"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1097\/00042728-200802000-00012","article-title":"Surgical treatment of hidradenitis suppurativa with gentamicin sulfate: a prospective randomized study","volume":"34","author":"Buimer MG","year":"2008","journal-title":"Dermatol Surg"},{"issue":"Suppl 2","key":"ref54","first-page":"S32","article-title":"Management of patients with hidradenitis suppurativa","volume":"107","author":"Martorell A","year":"2016","journal-title":"Actas Dermosifiliogr"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1111\/bjd.14418","article-title":"Interventions for hidradenitis suppurativa: a Cochrane systematic review incorporating GRADE assessment of evidence quality","volume":"174","author":"Ingram JR","year":"2016","journal-title":"Br J Dermatol"},{"key":"ref56","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1111\/j.1365-2230.2009.03377.x","article-title":"Resorcinol peels as a possible self-treatment of painful nodules in hidradenitis suppurativa","volume":"35","author":"Boer J","year":"2010","journal-title":"Clin Exp Dermatol"},{"key":"ref57","first-page":"697","article-title":"Actualizaci\u00f3n en hidradenitis supurativa (II): aspectos terap\u00e9uticos","volume":"106","author":"Martorell A","year":"2015","journal-title":"Actas Dermosifiliogr"},{"key":"ref58","series-title":"Hidradenitis Suppurativa","first-page":"138","author":"Jemec GBE","year":"2006"},{"key":"ref59","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1046\/j.1365-2230.2001.00876.x","article-title":"Early-onset hidradenitis suppurativa","volume":"26","author":"Palmer RA","year":"2001","journal-title":"Clin Exp Dermatol"},{"key":"ref60","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.clindermatol.2014.12.007","article-title":"Hidradenitis Suppurativa in prepubescent and pubescent children","volume":"33","author":"Scheinfeld N","year":"2015","journal-title":"Clin Dermatol"},{"key":"ref61","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.jaad.2014.11.017","article-title":"Correlation of early onset hidradenitis suppurativa with stronger genetic susceptibility and more widespread involvement","volume":"72","author":"Deckers IE","year":"2015","journal-title":"J Am Acad Dermatol"},{"key":"ref62","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1007\/s40272-014-0091-3","article-title":"Hidradenitis suppurativa in children and adolescents: a review of treatment options","volume":"16","author":"Mikkelsen PR","year":"2014","journal-title":"Paediatr Drugs"},{"key":"ref63","doi-asserted-by":"crossref","first-page":"294","DOI":"10.4103\/0378-6323.152741","article-title":"Prepubertal onset of hidradenitis suppurativa in a girl: A case report and literature review","volume":"81","author":"Stojkovic-Filipovic JM","year":"2015","journal-title":"Indian J Dermatol Venereol Leprol"},{"issue":"Suppl 1","key":"ref64","doi-asserted-by":"crossref","first-page":"S36","DOI":"10.1016\/j.jaad.2015.07.051","article-title":"Hidradenitis suppurativa in the pediatric population","volume":"73","author":"Liy-Wong C","year":"2015","journal-title":"J Am Acad Dermatol"},{"key":"ref65","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1001\/jamadermatol.2013.2874","article-title":"Finasteride for the treatment of hidradenitis suppurativa in children and adolescents","volume":"149","author":"Randhawa HK","year":"2013","journal-title":"JAMA Dermatol"},{"key":"ref66","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1111\/j.1524-4725.2009.01231.x","article-title":"Prepubertal hidradenitis suppurativa successfully treated with botulinum toxin A","volume":"35","author":"Feito-Rodr\u00edguez M","year":"2009","journal-title":"Dermatol Surg"},{"key":"ref67","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1097\/MOP.0000000000000253","article-title":"Current concepts in the management of hidradenitis suppurativa in children","volume":"27","author":"Danby FW","year":"2015","journal-title":"Curr Opin Pediatr"},{"key":"ref68","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1111\/j.1365-2133.1986.tb05740.x","article-title":"A double-blind crossover trial of cyproterone acetate in females with hidradenitis suppurativa","volume":"115","author":"Mortimer PS","year":"1986","journal-title":"Br J Dermatol"},{"key":"ref69","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1111\/bjd.12104","article-title":"Systemic therapy with immunosuppressive agents and retinoids in hidradenitis suppurativa: a systematic review","volume":"168","author":"Blok JL","year":"2013","journal-title":"Br J Dermatol"},{"key":"ref70","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1038\/jid.1958.124","article-title":"Preliminar y studies of the effect of hydrocortisone on hidradenitis suppurativa","volume":"31","author":"Danto JL","year":"1958","journal-title":"J Invest Dermatol"},{"key":"ref71","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1111\/j.1468-3083.2012.04668.x","article-title":"Metformin for the treatment of hidradenitis suppurativa: A little help along the way","volume":"27","author":"Verdolini R","year":"2013","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"ref72","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1159\/000100883","article-title":"Hidradenitis suppurativa and zinc: a new therapeutic approach","volume":"214","author":"Brocard A","year":"2007","journal-title":"Dermatology"},{"key":"ref73","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1159\/000228334","article-title":"Combination therapy with clindamycin and rifampicin for hidradenitis suppurativa: a series of 116 consecutive patients","volume":"219","author":"Gener G","year":"2009","journal-title":"Dermatology"},{"key":"ref74","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1111\/j.1365-2133.2006.07155.x","article-title":"Clindamycin and rifampicin combination therapy for hidradenitis suppurativa","volume":"154","author":"Mendon\u00e7a CO","year":"2006","journal-title":"Br J Dermatol"},{"key":"ref75","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1159\/000228337","article-title":"The effect of combined treatment with oral clindamycin and oral rifampicin in patients with hidradenitis suppurativa","volume":"219","author":"van der Zee HH","year":"2009","journal-title":"Dermatology"},{"key":"ref76","doi-asserted-by":"crossref","first-page":"e15","DOI":"10.1111\/bjd.15739","article-title":"Oral ofloxacin and clindamycin as an alternative to the classic rifampicin clindamycin in hidradenitis suppurativa: retrospective analysis of 65 patients","volume":"178","author":"Delaunay J","year":"2018","journal-title":"Br J Dermatol"},{"key":"ref77","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1111\/ijd.13428","article-title":"Hidradenitis suppurativa treated with tetracycline in combination with colchicin: a prospective series of 20 patients","volume":"56","author":"Armyra K","year":"2017","journal-title":"Int J Dermatol"},{"key":"ref78","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1159\/000329023","article-title":"Dapsone therapy for hidradenitis suppurativa: a series of 24 patients","volume":"222","author":"Yazdanyar S","year":"2011","journal-title":"Dermatology"},{"key":"ref79","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1080\/09546630600830588","article-title":"Hidradenitis suppurativa treated with dapsone: a case series of five patients","volume":"17","author":"Kaur MR","year":"2006","journal-title":"J Dermatolog Treat"},{"key":"ref80","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1159\/000182261","article-title":"Absence of efficacy of oral isotretinoin in hidradenitis suppurativa: a retrospective study based on patients' outcome assessment","volume":"218","author":"Soria A","year":"2009","journal-title":"Dermatology"},{"key":"ref81","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0190-9622(99)70530-X","article-title":"Long-term results of isotretinoin in the treatment of 68 patients with hidradenitis suppurativa","volume":"40","author":"Boer J","year":"1999","journal-title":"J Am Acad Dermatol"},{"key":"ref82","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/0002-9378(88)90766-1","article-title":"Hidradenitis suppurativa of the ano- genital region: response to isotretinoin","volume":"158","author":"Brown CF","year":"1988","journal-title":"Am J Obstet Gynecol"},{"key":"ref83","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/S0190-9622(84)70199-X","article-title":"Evaluation of isotretinoin treatment of hidradenitis suppurativa","volume":"11","author":"Dicken CH","year":"1984","journal-title":"J Am Acad Dermatol"},{"key":"ref84","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1111\/j.1365-2133.1982.tb00351.x","article-title":"Hidradenitis suppurativa-lack of success with 13-cis-retinoic acid","volume":"107","author":"Jones DH","year":"1982","journal-title":"Br J Dermatol"},{"key":"ref85","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1111\/j.1365-2230.1986.tb00512.x","article-title":"Failure of treatment of familial widespread hidradenitis suppurativa with isotretinoin","volume":"11","author":"Norris JF","year":"1986","journal-title":"Clin Exp Dermatol"},{"key":"ref86","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1111\/j.1365-2133.2010.10071.x","article-title":"Long-term results of acitretin therapy for hidradenitis suppurativa. Is acne inversa also a misnomer?","volume":"164","author":"Boer J","year":"2011","journal-title":"Br J Dermatol"},{"key":"ref87","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1111\/bjd.12884","article-title":"Acitretin treatment for hidradenitis suppurativa: a prospective series of 17 patients","volume":"171","author":"Matusiak L","year":"2014","journal-title":"Br J Dermatol"},{"key":"ref88","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1111\/j.1365-2133.1992.tb00693.x","article-title":"Successful treatment of hidradenitis suppurativa and retroauricular acne with etretinate","volume":"126","author":"Chow ET","year":"1992","journal-title":"Br J Dermatol"},{"key":"ref89","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/S0190-9622(88)80251-2","article-title":"Successful treatment of hidradenitis suppurativa with acitretin","volume":"19","author":"Hogan DJ","year":"1988","journal-title":"J Am Acad Dermatol"},{"key":"ref90","first-page":"287","article-title":"Nodulocystic acne and hidradenitis suppurativa treated with acitretin: a case report","volume":"69","author":"Scheman AJ","year":"2002","journal-title":"Cutis"},{"key":"ref91","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1080\/09546634.2018.1445194","article-title":"Dermatological indications for the use of isotretinoin beyond acne","volume":"29","author":"Forbat E","year":"2018","journal-title":"J Dermatolog Treat"},{"key":"ref92","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1016\/S0190-9622(99)80077-2","article-title":"Long-term results of isotretinoin in the treatment of 68 patients with hidradenitis suppurativa","volume":"41","author":"Jemec GB","year":"1999","journal-title":"J Am Acad Dermatol"},{"key":"ref93","doi-asserted-by":"crossref","first-page":"8018192","DOI":"10.1155\/2017\/8018192","article-title":"Review of the current immunologic therapies for Hidradenitis suppurativa","volume":"2017","author":"Shanmugam VK","year":"2017","journal-title":"Int J Rheumatol"},{"key":"ref94","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1097\/00054725-200111000-00008","article-title":"Hidradenitis suppurativa and Crohn's disease: response to treatment with infliximab","volume":"7","author":"Mart\u00ednez F","year":"2001","journal-title":"Inflamm Bowel Dis"},{"key":"ref95","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0203672","article-title":"Integrating the skin and blood transcriptomes and serum proteome in hidradenitis suppurativa reveals complement dysregulation and a plasma cell signature","volume":"13","author":"Hoffman LK","year":"2018","journal-title":"PLoS One"},{"key":"ref96","doi-asserted-by":"crossref","first-page":"393","DOI":"10.5021\/ad.2012.24.4.393","article-title":"Acne inversa: evaluating antimicrobial peptides and proteins","volume":"24","author":"Bechara FG","year":"2012","journal-title":"Ann Dermatol"},{"key":"ref97","doi-asserted-by":"crossref","first-page":"82","DOI":"10.5114\/ada.2017.65626","article-title":"Increased serum interleukin-6 levels in patients with hidradenitis suppurativa","volume":"34","author":"Xu H","year":"2017","journal-title":"Postepy Dermatol Alergol"},{"key":"ref98","doi-asserted-by":"crossref","first-page":"105","DOI":"10.2147\/CCID.S111019","article-title":"Hidradenitis suppurativa: from pathogenesis to diagnosis and treatment","volume":"10","author":"Napolitano M","year":"2017","journal-title":"Clin Cosmet Investig Dermatol"},{"key":"ref99","article-title":"Hidradenitis suppurativa\/acne inversa: A practical framework for treatment optimization systematic review and recommendations from the HS ALLIANCE working group","author":"Zouboulis CC","year":"2018","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"ref100","first-page":"731","article-title":"Hidradenitis suppurativa: guidelines of the Italian Society of Dermatology and Venereology (SIDeMaST) for the use of anti-TNF-\u03b1 agents","volume":"150","author":"Megna M","year":"2015","journal-title":"G Ital Dermatol Venereol"},{"issue":"Suppl 1","key":"ref101","doi-asserted-by":"crossref","first-page":"S82","DOI":"10.1016\/j.jaad.2015.07.053","article-title":"Treatment of hidradenitis suppurativa with biologic medications","volume":"73","author":"Lee RA","year":"2015","journal-title":"J Am Acad Dermatol"},{"key":"ref102","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1159\/000477459","article-title":"Swiss Practice Recommendations for the Management of Hidradenitis Suppurativa\/Acne Inversa","volume":"233","author":"Hunger RE","year":"2017","journal-title":"Dermatology"},{"key":"ref103","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1177\/1203475417716117","article-title":"Approach to the Management of Patients With Hidradenitis Suppurativa: A Consensus Document","volume":"21","author":"Alavi A","year":"2017","journal-title":"J Cutan Med Surg"},{"key":"ref104","first-page":"584","article-title":"Hidradenitis suppurativa - Management, comorbidities and monitoring","volume":"46","author":"Vekic DA","year":"2017","journal-title":"Aust Fam Physician"},{"key":"ref105","first-page":"127","article-title":"Hidradenitis suppurativa - symptoms, diagnostics, and therapy","volume":"156","author":"Arenbergerov\u00e1 M","year":"2017","journal-title":"Cas Lek Cesk"},{"key":"ref106","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1001\/jamadermatol.2017.0432","article-title":"Interventions for Hidradenitis Suppurativa: Updated Summary of an Original Cochrane Review","volume":"153","author":"Ingram JR","year":"2017","journal-title":"JAMA Dermatol"},{"key":"ref107","series-title":"Adalimumabe (Humira)"},{"key":"ref108","doi-asserted-by":"crossref","first-page":"846","DOI":"10.7326\/0003-4819-157-12-201212180-00004","article-title":"Adalimumab for the treatment of moderate to severe Hidradenitis suppurativa: a parallel randomized trial","volume":"157","author":"Kimball AB","year":"2012","journal-title":"Ann Intern Med"},{"key":"ref109","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1056\/NEJMoa1504370","article-title":"Two Phase 3 Trials of Adalimumab for Hidradenitis Suppurativa","volume":"375","author":"Kimball AB","year":"2016","journal-title":"N Engl J Med"},{"key":"ref110","first-page":"E98","article-title":"Infection-free clinical response among patients with hidradenitis suppurativa who were treated with adalimumab: results from two phase 3 studies","volume":"29","author":"Giamarellos-Bourboulis EJ","year":"2017","journal-title":"Wounds"},{"key":"ref111","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1097\/SAP.0000000000000584","article-title":"Outcomes after combined radical resection and targeted biologic therapy for the management of recalcitrant hidradenitis suppurativa","volume":"77","author":"DeFazio MV","year":"2016","journal-title":"Ann Plast Surg"},{"key":"ref112","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.jaad.2009.06.050","article-title":"Infliximab therapy for patients with moderate to severe hidradenitis suppurativa: a randomized, double- blind, placebo-controlled crossover trial","volume":"62","author":"Grant A","year":"2010","journal-title":"J Am Acad Dermatol"},{"key":"ref113","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1111\/bjd.12713","article-title":"Four-weekly infliximab in the treatment of severe hidradenitis suppurativa","volume":"170","author":"Moriarty B","year":"2014","journal-title":"Br J Dermatol"},{"key":"ref114","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1111\/j.1365-2133.2005.07067.x","article-title":"Etanercept: effective in the management of hidradenitis suppurativa","volume":"154","author":"Cusack C","year":"2006","journal-title":"Br J Dermatol"},{"key":"ref115","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1111\/j.1365-2133.2007.08372.x","article-title":"An open-label phase II study of the safety and efficacy of etanercept for the therapy of hidradenitis suppurativa","volume":"158","author":"Giamarellos-Bourboulis EJ","year":"2008","journal-title":"Br J Dermatol"},{"key":"ref116","doi-asserted-by":"crossref","first-page":"82","DOI":"10.2340\/00015555-0545","article-title":"Etanercept for the treatment of hidradenitis suppurativa","volume":"89","author":"Sotiriou E","year":"2009","journal-title":"Acta Derm Venereol"},{"key":"ref117","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1111\/j.1468-3083.2011.04123.x","article-title":"Experience with ustekinumab for the treatment of moderate to severe hidradenitis suppurativa","volume":"26","author":"Gulliver WP","year":"2012","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"ref118","doi-asserted-by":"crossref","first-page":"320","DOI":"10.2340\/00015555-1229","article-title":"Management of recalcitrant hidradenitis suppurativa with ustekinumab","volume":"92","author":"Sharon VR","year":"2012","journal-title":"Acta Derm Venereol"},{"key":"ref119","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1136\/annrheumdis-2012-202392","article-title":"Successful long-term triple disease control by ustekinumab in a patient with Behcet's disease, psoriasis and hidradenitis suppurativa","volume":"72","author":"Baerveldt EM","year":"2013","journal-title":"Ann Rheum Dis"},{"key":"ref120","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1016\/j.ad.2013.09.011","article-title":"Ustekinumab for hidradenitis suppurativa: a case report","volume":"105","author":"Santos-P\u00e9rez MI","year":"2014","journal-title":"Actas Dermosifiliogr"},{"key":"ref121","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1111\/bjd.14338","article-title":"Ustekinumab in hidradenitis suppurativa: clinical results and a search for potential biomarkers in serum","volume":"174","author":"Blok JL","year":"2016","journal-title":"Br J Dermatol"},{"key":"ref122","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1684\/ejd.2013.2018","article-title":"Pyoderma gangrenosum and concomitant hidradenitis suppurativa--rapid response to canakinumab (anti-IL-1\u03b2)","volume":"23","author":"Jaeger T","year":"2013","journal-title":"Eur J Dermatol"},{"key":"ref123","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.jdcr.2016.07.007","article-title":"The role of interleukin-1\u03b2 in pyoderma gangrenosum","volume":"2","author":"Galimberti RL","year":"2016","journal-title":"JAAD Case Rep"},{"key":"ref124","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1001\/jamadermatol.2017.2392","article-title":"Canakinumab for Severe Hidradenitis Suppurativa: Preliminary Experience in 2 Cases","volume":"153","author":"Houriet C","year":"2017","journal-title":"JAMA Dermatol"},{"key":"ref125","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1016\/j.jaad.2016.10.042","article-title":"Increased interleukin (IL)-17 serum levels in patients with hidradenitis suppurativa: Implications for treatment with anti-IL-17 agents","volume":"76","author":"Matusiak \u0141","year":"2017","journal-title":"J Am Acad Dermatol"},{"key":"ref126","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1111\/bjd.15769","article-title":"Severe hidradenitis suppurativa responding to treatment with secukinumab: a case report","volume":"179","author":"Thorlacius L","year":"2018","journal-title":"Br J Dermatol"},{"key":"ref127","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1016\/S0149-2918(02)80023-6","article-title":"A randomized, double-blind comparison of a clindamycin phosphate\/benzoyl peroxide gel formulation and a matching clindamycin gel with respect to microbiologic activity and clinical efficacy in the topical treatment of acne vulgaris","volume":"24","author":"Cunliffe WJ","year":"2002","journal-title":"Clin Ther"},{"key":"ref128","doi-asserted-by":"crossref","first-page":"2367","DOI":"10.1093\/jac\/dkw135","article-title":"Addressing resistance to antibiotics in systematic reviews of antibiotic interventions","volume":"71","author":"Leibovici L","year":"2016","journal-title":"J Antimicrob Chemother"},{"key":"ref129","doi-asserted-by":"crossref","first-page":"309.e2","DOI":"10.1016\/j.jaad.2016.08.001","article-title":"Patterns of antimicrobial resistance in lesions of hidradenitis suppurativa","volume":"76","author":"Fischer AH","year":"2017","journal-title":"J Am Acad Dermatol"},{"key":"ref130","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1111\/bjd.16013","article-title":"Development of resistance to Mycobacterium tuberculosis is manageable in hidradenitis suppurativa. Response to treatment of hidradenitis suppurativa with rifampicin: have we forgotten tuberculosis?","volume":"178","author":"Albrecht J","year":"2018","journal-title":"Br J Dermatol"},{"key":"ref131","first-page":"206","article-title":"Hidradenite supurativa: atualiza\u00e7\u00e3o e revis\u00e3o de suas modalidades terap\u00eauticas","volume":"6","author":"Muzy G","year":"2014","journal-title":"Surg Cosm Dermatol"},{"key":"ref132","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1159\/000462979","article-title":"Medical and Surgical Treatment of Hidradenitis Suppurativa: A Review","volume":"3","author":"Scuderi N","year":"2017","journal-title":"Skin Appendage Disord"},{"key":"ref133","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1080\/09546634.2017.1360989","article-title":"The increasing relevance of biofilms in common dermatological conditions","volume":"29","author":"Kravvas G","year":"2018","journal-title":"J Dermatolog Treat"},{"key":"ref134","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.jaad.2009.12.018","article-title":"Deroofing: a tissue-saving surgical technique for the treatment of mild to moderate hidradenitis suppurativa lesions","volume":"63","author":"van der Zee HH","year":"2010","journal-title":"J Am Acad Dermatol"},{"key":"ref135","first-page":"835","article-title":"Surgical approach to extensive hidradenitis suppurativa","volume":"37","author":"B\u00fcy\u00fcka\u015fik O","year":"2011","journal-title":"Dermatol Surg"},{"key":"ref136","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1111\/j.1524-4725.2011.02186.x","article-title":"Hidradenitis suppurativa: surgical and other management techniques","volume":"38","author":"Lixia ZE","year":"2012","journal-title":"Dermatol Surg"},{"key":"ref137","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1136\/bmj.294.6570.487","article-title":"Recurrence after surgical treatment of hidradenitis suppurativa","volume":"294","author":"Harrison BJ","year":"1987","journal-title":"Br Med J (Clin Res Ed)"},{"key":"ref138","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1046\/j.1524-4725.2000.00043.x","article-title":"Long-term results of wide surgical excision in 106 patients with hidradenitis suppurativa","volume":"26","author":"Rompel R","year":"2000","journal-title":"Dermatol Surg"},{"key":"ref139","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1177\/000313481808400328","article-title":"Axillary Hidradenitis: Risk factors for recurrence after surgical excision in 214 patients","volume":"84","author":"Nweze N","year":"2018","journal-title":"Am Surg"},{"key":"ref140","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1111\/jdv.14770","article-title":"Hidradenitis suppurativa treated with wide excision and second intention healing: a meaningful local cure rate after 253 procedures","volume":"32","author":"Deckers IE","year":"2018","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"ref141","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1111\/jdv.14892","article-title":"Surgical treatment of hidradenitis suppurativa: an analysis of postoperative outcome, cosmetic results and quality of life in 255 patients","volume":"32","author":"Kofler L","year":"2018","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"ref142","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1111\/ijd.13798","article-title":"Longitudinal observational study of hidradenitis suppurativa: impact of surgical intervention with adjunctive biologic therapy","volume":"57","author":"Shanmugam VK","year":"2018","journal-title":"Int J Dermatol"},{"key":"ref143","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1111\/j.1524-4725.2009.01427.x","article-title":"Hidradenitis suppurativa: Successful treatment using carbon dioxide laser excision and marsupialization","volume":"36","author":"Hazen PG","year":"2010","journal-title":"Dermatol Surg"},{"key":"ref144","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/S0190-9622(96)90441-7","article-title":"Treatment of hidradenitis suppurativa with carbon dioxide laser excision and second-intention healing","volume":"34","author":"Finley EM","year":"1996","journal-title":"J Am Acad Dermatol"},{"key":"ref145","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1111\/j.1365-2133.2008.08932.x","article-title":"Outcomes of treatment of nine cases of recalcitrant severe hidradenitis suppurativa with carbon dioxide laser","volume":"159","author":"Madan V","year":"2008","journal-title":"Br J Dermatol"},{"key":"ref146","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1097\/DSS.0000000000000264","article-title":"Recurrence rate and patient satisfaction of CO2 laser evapration of lesions in patients with hidradenitis suppurativa: a retrospective study","volume":"41","author":"Mikkelsen PR","year":"2015","journal-title":"Dermatol Surg"},{"key":"ref147","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1097\/PRS.0b013e31821e6fb5","article-title":"Treatment of hidradenitis suppurativa with intense pulsed light: a prospective study","volume":"128","author":"Highton L","year":"2011","journal-title":"Plast Reconstr Surg"},{"key":"ref148","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.det.2015.08.001","article-title":"Lasers and Intense Pulsed Light hidradenitis supurativa","volume":"34","author":"Saunte DM","year":"2016","journal-title":"Dermatol Clin"}],"container-title":["Anais Brasileiros de Dermatologia"],"original-title":[],"link":[{"URL":"http:\/\/www.scielo.br\/pdf\/abd\/v94n2s1\/0365-0596-abd-94-02-s1-0007.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,19]],"date-time":"2025-05-19T15:00:46Z","timestamp":1747666846000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.scielo.br\/scielo.php?script=sci_arttext&pid=S0365-05962019000700007&tlng=en"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4]]},"references-count":148,"journal-issue":{"issue":"2 suppl 1","published-online":{"date-parts":[[2019,4]]}},"alternative-id":["S0365-05962019000700007"],"URL":"https:\/\/doi.org\/10.1590\/abd1806-4841.20198607","relation":{},"ISSN":["1806-4841","0365-0596"],"issn-type":[{"value":"1806-4841","type":"electronic"},{"value":"0365-0596","type":"print"}],"subject":[],"published":{"date-parts":[[2019,4]]}}}